Wall Street analysts expect that Exponent, Inc. (NASDAQ:EXPO) will post $0.33 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Exponent’s earnings, with the lowest EPS estimate coming in at $0.32 and the highest estimate coming in at $0.33. Exponent posted earnings of $0.34 per share in the same quarter last year, which would suggest a negative year-over-year growth rate of 2.9%. The firm is scheduled to report its next earnings results on Thursday, July 18th.

According to Zacks, analysts expect that Exponent will report full-year earnings of $1.42 per share for the current financial year, with EPS estimates ranging from $1.42 to $1.43. For the next fiscal year, analysts forecast that the business will report earnings of $1.53 per share, with EPS estimates ranging from $1.51 to $1.56. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research firms that that provide coverage for Exponent.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings data on Thursday, April 18th. The business services provider reported $0.42 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.07. Exponent had a return on equity of 23.10% and a net margin of 19.53%. The company had revenue of $93.40 million for the quarter, compared to analyst estimates of $93.52 million. During the same quarter last year, the firm earned $0.75 EPS. Exponent’s revenue for the quarter was up 3.0% compared to the same quarter last year.

EXPO has been the topic of several recent analyst reports. William Blair reaffirmed a “market perform” rating on shares of Exponent in a research note on Monday, April 22nd. BidaskClub raised Exponent from a “hold” rating to a “buy” rating in a research note on Thursday, February 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $64.00 price target (up previously from $56.00) on shares of Exponent in a research note on Monday, April 22nd. Finally, Zacks Investment Research raised Exponent from a “hold” rating to a “buy” rating and set a $56.00 price target on the stock in a research note on Monday, February 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Exponent presently has an average rating of “Buy” and a consensus target price of $61.33.

Shares of NASDAQ:EXPO opened at $55.34 on Tuesday. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.06. The company has a market cap of $2.91 billion, a PE ratio of 44.27 and a beta of 0.44. Exponent has a 1-year low of $44.44 and a 1-year high of $59.80.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 21st. Investors of record on Friday, June 7th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 1.16%. The ex-dividend date is Thursday, June 6th. Exponent’s dividend payout ratio is 51.20%.

In related news, Director Carol Lindstrom sold 1,800 shares of the business’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $56.92, for a total value of $102,456.00. Following the sale, the director now owns 3,212 shares of the company’s stock, valued at approximately $182,827.04. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.30% of the stock is owned by insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Bronfman E.L. Rothschild L.P. raised its position in Exponent by 580.9% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 926 shares of the business services provider’s stock valued at $47,000 after purchasing an additional 790 shares during the last quarter. Bremer Bank National Association bought a new stake in shares of Exponent during the first quarter worth $55,000. Quadrant Capital Group LLC raised its position in shares of Exponent by 961.2% during the first quarter. Quadrant Capital Group LLC now owns 1,040 shares of the business services provider’s stock worth $57,000 after acquiring an additional 942 shares during the last quarter. Bremer Trust National Association bought a new stake in shares of Exponent during the fourth quarter worth $55,000. Finally, Quantamental Technologies LLC bought a new stake in shares of Exponent during the fourth quarter worth $132,000. Hedge funds and other institutional investors own 88.80% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.

Featured Story: Market Perform

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.